Climate & Science|$62.0k Vol|
287 days 6 hrsCDC issues Level 4 warning by December 31? - AI Odds Analysis
All
Outcomes
Market
Price
AI Fair
Value
Value
Edge
YesNo
AI Insights:
2 hours ago UpdatedFair Value Reasoning:
Despite chatter about escalating measles outbreaks and HHS policy disruptions, the CDC's strict criteria (effective April 2022) reserve Level 4 ('Avoid All Travel') notices solely for 'Special Circumstances' like healthcare collapse or new variants. The Marburg outbreak in Ethiopia officially ended in January 2026, H5N1 risk remains 'Low', and measles/polio typically only trigger Level 1 or 2 advisories. Thus, the fundamental probability of a Level 4 issuance is minimal, suggesting the current 10.5c price is overvalued.
Sign up to view more information
Hedging
Crude Oil
PFE
CCL
DAL
S&P 500
A CDC Level 4 warning typically signals a serious epidemic outbreak (similar to early COVID), leading directly to travel restrictions and panic. This would severely hit airlines (DAL), cruise lines (CCL), and crude oil prices, while potentially benefiting vaccine stocks (PFE). It would also cause significant risk-off sentiment in broad indices (S&P 500).
Divergence
Significant divergence exists. Some AI analytics models (e.g., cited by Perplexity) argue the market is underpriced (valuing it at ~18.5%) due to surging measles cases and political uncertainty under RFK Jr. However, the actual prediction market price has corrected down to 10.5%, aligning more closely with the CDC's strict technical criteria (where measles rarely meets the 'healthcare collapse' threshold for Level 4), indicating the market is pricing in structural constraints better than alarmist models.
